Characteristics | N (%) |
---|---|
Age (years) | mean 62 (range 32–76) |
Primary cytoreduction | 30 (57.7%) |
Secondary cytoreduction | 22 (42.3%) |
Previous chemotherapy | Â |
   None | 22 (42.3%) |
   Adjuvant | 22 (42.3%) |
   Neoadjuvant | 8 (15.4%) |
Performance status (WHO) | Â |
   0 | 18 (34.6%) |
   1 | 17 (32.7%) |
   2 | 17 (32.7%) |
Intestinal obstruction | Â |
   Absent | 35 (67.3%) |
   Present | 17 (32.7%) |
Ascites | Â |
   Absent | 19 (36.5%) |
   Present | 33 (63.5%) |
Comorbidity | Â |
   Absent | 38 (73.1%) |
   Present | 14 (26.9%) |
Ca125 level | mean 579.25 U/ml (range 15 to 6800 U/ml) |
Peritoneal cancer index (PCI) | mean 18.8 (range 6 to 28) |